feed,title,long_url,short_url
🔐MarketWatch,23andMe stock rallies more than 23% after genetics company gets OK to report more cancer risks,http://www.marketwatch.com/news/story/23andme-stock-rallies-more-23/story.aspx?guid=%7B20C06575%2D04D4%2DB545%2D7259%2D6E47780E415D%7D&siteid=rss,https://da.gd/OMZW
